These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 23463262)

  • 1. Chitosan-modified PLGA nanoparticles with versatile surface for improved drug delivery.
    Wang Y; Li P; Kong L
    AAPS PharmSciTech; 2013 Jun; 14(2):585-92. PubMed ID: 23463262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PLGA nanoparticles for the oral delivery of 5-Fluorouracil using high pressure homogenization-emulsification as the preparation method and in vitro/in vivo studies.
    Li X; Xu Y; Chen G; Wei P; Ping Q
    Drug Dev Ind Pharm; 2008 Jan; 34(1):107-15. PubMed ID: 18214762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and in vitro evaluation of surface modified poly(lactide-co-glycolide) nanoparticles with chitosan-4-thiobutylamidine.
    Grabovac V; Bernkop-Schnürch A
    Drug Dev Ind Pharm; 2007 Jul; 33(7):767-74. PubMed ID: 17654025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability.
    Badran MM; Alomrani AH; Harisa GI; Ashour AE; Kumar A; Yassin AE
    Biomed Pharmacother; 2018 Oct; 106():1461-1468. PubMed ID: 30119220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modification of the release characteristics of estradiol encapsulated in PLGA particles via surface coating.
    Enayati M; Stride E; Edirisinghe M; Bonfield W
    Ther Deliv; 2012 Feb; 3(2):209-26. PubMed ID: 22834198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved mucoadhesion and cell uptake of chitosan and chitosan oligosaccharide surface-modified polymer nanoparticles for mucosal delivery of proteins.
    Dyawanapelly S; Koli U; Dharamdasani V; Jain R; Dandekar P
    Drug Deliv Transl Res; 2016 Aug; 6(4):365-79. PubMed ID: 27106502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chitosan-modified PLGA nanoparticles tagged with 5TR1 aptamer for in vivo tumor-targeted drug delivery.
    Taghavi S; Ramezani M; Alibolandi M; Abnous K; Taghdisi SM
    Cancer Lett; 2017 Aug; 400():1-8. PubMed ID: 28412238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of rabies pDNA nanoparticulate vaccine in poloxamer 407 gel.
    Bansal A; Wu X; Olson V; D'Souza MJ
    Int J Pharm; 2018 Jul; 545(1-2):318-328. PubMed ID: 29746999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PLGA Microparticles Entrapping Chitosan-Based Nanoparticles for the Ocular Delivery of Ranibizumab.
    Elsaid N; Jackson TL; Elsaid Z; Alqathama A; Somavarapu S
    Mol Pharm; 2016 Sep; 13(9):2923-40. PubMed ID: 27286558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface modification of PLGA nanoparticles with biotinylated chitosan for the sustained in vitro release and the enhanced cytotoxicity of epirubicin.
    Chen H; Xie LQ; Qin J; Jia Y; Cai X; Nan W; Yang W; Lv F; Zhang QQ
    Colloids Surf B Biointerfaces; 2016 Feb; 138():1-9. PubMed ID: 26638176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fabrication and Use of Poly(d,l-lactide-co-glycolide)-Based Formulations Designed for Modified Release of 5-Fluorouracil.
    Leelakanok N; Geary S; Salem A
    J Pharm Sci; 2018 Feb; 107(2):513-528. PubMed ID: 29045885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation, characterization, and in vitro and in vivo investigation of chitosan-coated poly (d,l-lactide-co-glycolide) nanoparticles for intestinal delivery of exendin-4.
    Wang M; Zhang Y; Feng J; Gu T; Dong Q; Yang X; Sun Y; Wu Y; Chen Y; Kong W
    Int J Nanomedicine; 2013; 8():1141-54. PubMed ID: 23658482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-acting inhalable chitosan-coated poly(lactic-co-glycolic acid) nanoparticles containing hydrophobically modified exendin-4 for treating type 2 diabetes.
    Lee C; Choi JS; Kim I; Oh KT; Lee ES; Park ES; Lee KC; Youn YS
    Int J Nanomedicine; 2013; 8():2975-83. PubMed ID: 23976850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological evaluation of 5-fluorouracil nanoparticles for cancer chemotherapy and its dependence on the carrier, PLGA.
    Nair K L; Jagadeeshan S; Nair SA; Kumar GS
    Int J Nanomedicine; 2011; 6():1685-97. PubMed ID: 21980233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of sorafenib-loaded poly (lactic/glycolic) acid and DPPC liposome nanoparticles in the in vitro treatment of renal cell carcinoma.
    Liu J; Boonkaew B; Arora J; Mandava SH; Maddox MM; Chava S; Callaghan C; He J; Dash S; John VT; Lee BR
    J Pharm Sci; 2015 Mar; 104(3):1187-96. PubMed ID: 25573425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding the adsorption mechanism of chitosan onto poly(lactide-co-glycolide) particles.
    Guo C; Gemeinhart RA
    Eur J Pharm Biopharm; 2008 Oct; 70(2):597-604. PubMed ID: 18602994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chitosan-Coated Poly(lactic-co-glycolic acid)-Diiodinated boron-Dipyrromethene Nanoparticles Improve Tumor Selectivity and Stealth Properties in Photodynamic Cancer Therapy.
    Voon SH; Tiew SX; Kue CS; Lee HB; Kiew LV; Misran M; Kamkaew A; Burgess K; Chung LY
    J Biomed Nanotechnol; 2016 Jul; 12(7):1431-52. PubMed ID: 29336539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Method for Preparing Surface-Modified Fluocinolone Acetonide Loaded PLGA Nanoparticles for Ocular Use: In Vitro and In Vivo Evaluations.
    Salama AH; Mahmoud AA; Kamel R
    AAPS PharmSciTech; 2016 Oct; 17(5):1159-72. PubMed ID: 26589410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative studies on chitosan and polylactic-co-glycolic acid incorporated nanoparticles of low molecular weight heparin.
    Yang T; Nyiawung D; Silber A; Hao J; Lai L; Bai S
    AAPS PharmSciTech; 2012 Dec; 13(4):1309-18. PubMed ID: 23054983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
    Liu Y; Pan J; Feng SS
    Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.